Cargando…

Dyskinesia in Parkinson's Disease Therapy

Detalles Bibliográficos
Autores principales:	Carta, Anna Rosa, Giuffrida, Andrea, Fisone, Gilberto
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2012
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3530852/ https://www.ncbi.nlm.nih.gov/pubmed/23304638 http://dx.doi.org/10.1155/2012/639080

Ejemplares similares

Signal transduction in l-DOPA-induced dyskinesia: from receptor sensitization to abnormal gene expression
por: Spigolon, Giada, et al.
Publicado: (2018)

Foetal Cell Transplantation for Parkinson's Disease: Focus on Graft-Induced Dyskinesia
por: Tronci, Elisabetta, et al.
Publicado: (2015)

L-DOPA-Induced Dyskinesia and Abnormal Signaling in Striatal Medium Spiny Neurons: Focus on Dopamine D1 Receptor-Mediated Transmission
por: Feyder, Michael, et al.
Publicado: (2011)

Dyskinesias and Treatment with Pramipexole in Patients with Parkinson's Disease
por: Piedad, John C. P., et al.
Publicado: (2012)

Involvement of Autophagy in Levodopa‐Induced Dyskinesia
por: Feyder, Michael, et al.
Publicado: (2021)

Role of Serotonin Neurons in L-DOPA- and Graft-Induced Dyskinesia in a Rat Model of Parkinson's Disease
por: Shin, Eunju, et al.
Publicado: (2012)

Intestinal Decontamination Therapy for Dyskinesia and Motor Fluctuations in Parkinson's Disease
por: Baizabal-Carvallo, José Fidel, et al.
Publicado: (2021)

Distinct Changes in cAMP and Extracellular Signal-Regulated Protein Kinase Signalling in L-DOPA-Induced Dyskinesia
por: Santini, Emanuela, et al.
Publicado: (2010)

Rhabdomyolysis Related to Dyskinesia in Parkinson’s Disease
por: Bektaş, Hesna, et al.
Publicado: (2014)

Parkinson’s disease: carbidopa, nausea, and dyskinesia
por: Hinz, Marty, et al.
Publicado: (2014)

Surgical Treatment of Dyskinesia in Parkinson’s Disease
por: Munhoz, Renato P., et al.
Publicado: (2014)

A mouse model of non-motor symptoms in Parkinson's disease: focus on pharmacological interventions targeting affective dysfunctions
por: Bonito-Oliva, Alessandra, et al.
Publicado: (2014)

Sleep Disorders in Rodent Models of Parkinson’s Disease
por: Medeiros, Daniel de Castro, et al.
Publicado: (2019)

Clinically important change on the Unified Dyskinesia Rating Scale among patients with Parkinson's disease experiencing dyskinesia
por: Pahwa, Rajesh, et al.
Publicado: (2022)

“Cueing” for Levodopa-Induced Dyskinesias in Parkinson’s Disease
por: Schaeffer, Eva, et al.
Publicado: (2016)

Parkinson’s Disease: Carbidopa, Nausea, and Dyskinesia [Retraction]
Publicado: (2021)

PESISTENT PARKINSONISM AND TARDIVE DYSKINESIA
por: Shaji, K.S., et al.
Publicado: (1995)

Inhibition of mTORC1 Signaling Reverts Cognitive and Affective Deficits in a Mouse Model of Parkinson’s Disease
por: Masini, Débora, et al.
Publicado: (2018)

Reversibility of Tardive Dyskinesia Syndrome
por: Vinuela, Angel, et al.
Publicado: (2014)

Perspectives for Primary Ciliary Dyskinesia
por: Bukowy-Bieryllo, Zuzanna, et al.
Publicado: (2022)

Levodopa-induced dyskinesias in Parkinson’s disease: emerging treatments
por: Bargiotas, Panagiotis, et al.
Publicado: (2013)

Future Scenarios for Levodopa-Induced Dyskinesias in Parkinson’s Disease
por: Cerasa, Antonio, et al.
Publicado: (2015)

Surgical Treatment of Levodopa-induced Dyskinesia in Parkinson's Disease
por: Krishnan, Syam, et al.
Publicado: (2017)

Factors Associated With Dyskinesia in Parkinson's Disease in Mainland China
por: Zhou, Xun, et al.
Publicado: (2019)

Cerebellar connectivity in Parkinson's disease with levodopa‐induced dyskinesia
por: Yoo, Han Soo, et al.
Publicado: (2019)

Predictors of Levo-dopa induced Dyskinesias in Parkinson's Disease
por: Athulya, RT, et al.
Publicado: (2020)

Parkinson’s Disease: Carbidopa, Nausea, and Dyskinesia [Expression of Concern]
Publicado: (2020)

A Guide to the Generation of a 6-Hydroxydopamine Mouse Model of Parkinson’s Disease for the Study of Non-Motor Symptoms
por: Masini, Débora, et al.
Publicado: (2021)

Investigation of PRKN Mutations in Levodopa-Induced Dyskinesia in Parkinson’s Disease Treatment
por: Bispo, Ana Gabrielle, et al.
Publicado: (2023)

Mucus Plugging in Primary Ciliary Dyskinesia
por: Adaikalam, Stephanie, et al.
Publicado: (2023)

A(2A) Receptor Antagonism and Dyskinesia in Parkinson's Disease
por: Morelli, Micaela, et al.
Publicado: (2012)

Amantadine for Dyskinesias in Parkinson's Disease: A Randomized Controlled Trial
por: Sawada, Hideyuki, et al.
Publicado: (2010)

The acute brain response to levodopa heralds dyskinesias in Parkinson disease
por: Herz, Damian M., et al.
Publicado: (2014)

An updated meta-analysis of amantadine for treating dyskinesia in Parkinson's disease
por: Kong, Min, et al.
Publicado: (2017)

Persistent dyskinesias in patients with fetal tissue transplantation for Parkinson disease
por: Greene, Paul E., et al.
Publicado: (2021)

Dyskinesia-hyperpyrexia syndrome in Parkinson’s disease: a systematic review
por: Wang, Miao, et al.
Publicado: (2021)

High PSQI score is associated with the development of dyskinesia in Parkinson’s disease
por: Tang, Xiaohui, et al.
Publicado: (2022)

Genetic meta-analysis of levodopa induced dyskinesia in Parkinson’s disease
por: Martinez-Carrasco, Alejandro, et al.
Publicado: (2023)

Genetic meta-analysis of levodopa induced dyskinesia in Parkinson’s disease
por: Martinez-Carrasco, Alejandro, et al.
Publicado: (2023)

Low serum uric acid levels and levodopa-induced dyskinesia in Parkinson's disease
por: Soares, Nayron Medeiros, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_cclfs10ac045up0di0v2cebs0s